Триптизол

Quick links to important sections

Триптизол

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Триптизол

What is Triptizol (Amitriptyline)?

Property Description
Active Ingredient Amitriptyline Hydrochloride
Form Oral Tablet
Pharmacological Class Tricyclic Antidepressant (TCA)
Route of Administration Oral
Origin Synthetic Compound

Triptizol is a widely prescribed medication containing the active ingredient, amitriptyline hydrochloride, which acts on the central nervous system. It is classified as a tricyclic antidepressant (TCA) and is commonly dispensed as an oral tablet, requiring a doctor's prescription. Amitriptyline is recognized globally for its therapeutic actions and is considered an essential medicine.


Composition and Classification

The core component of Triptizol is the chemical compound amitriptyline hydrochloride, a synthetic substance. The drug belongs to the TCA class, a group of compounds that share a distinctive chemical structure and mode of action within the brain. Its classification as a TCA is a standard medical designation based on its chemical profile.


Pharmacological Action

As a tricyclic antidepressant, Triptizol exerts its primary effects by influencing key chemical messengers, or neurotransmitters, in the central nervous system. Its mechanism involves blocking the re-uptake of both serotonin and norepinephrine, thereby increasing their availability at nerve terminals. This pharmacological principle helps to modulate nerve signaling and is the basis of its effects on mood and pain perception. The medication is specifically formulated for oral administration, ensuring systemic absorption of the active ingredient through the digestive tract.

What side effects are possible with Триптизол?

Possible Side Effects and Safety Information

Триптизол (Amitriptyline), a tricyclic compound, carries officially documented risks across multiple system-organ classes, with frequency classifications ranging from Very Common (ge 1/10) to Rare (< 1/1,000).


Key Adverse Reactions and Safety Restrictions

Adverse reactions commonly involve the Nervous, Cardiovascular, and Gastrointestinal systems. Very Common side effects include dry mouth, somnolence, headache, dizziness, and constipation, which often relate to the drug's anticholinergic and sedative properties. Other common reactions include tremor, palpitations, and blurred vision.

Serious Safety Concerns

The most significant safety warning is an FDA-mandated Black Box Warning regarding the increased risk of suicidal thoughts and behavior in children, adolescents, and young adults (up to age 24) when initiating therapy or following a dose change. Serious cardiovascular risks include cardiac arrhythmias (such as QT prolongation), myocardial infarction, and stroke.

Safety Restrictions and Monitoring

Contraindications restrict use during the acute recovery phase following myocardial infarction and prohibit concomitant use with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of Serotonin Syndrome. Caution is advised for patients with a history of seizures, urinary retention, glaucoma, or pre-existing heart disease due to increased susceptibility to adverse effects. Elderly patients are particularly vulnerable to orthostatic hypotension and hyponatremia and typically require lower starting doses. Close monitoring for clinical worsening or the emergence of suicidal tendencies is required across all age groups.

Overdose and Emergency Response

The official regulatory profile for a Триптизол (Amitriptyline) overdose highlights the serious, potentially life-threatening risks associated with acute exposure, necessitating immediate medical intervention.

Overdose manifestations can progress rapidly. Initial signs often include drowsiness, confusion, fever, dilated pupils, and urinary retention. Critical manifestations, which require immediate medical intervention, primarily involve the cardiovascular and central nervous systems, leading to severe outcomes such as cardiac dysrhythmias, severe hypotension, convulsions, and coma. Specific ECG abnormalities, notably QRS prolongation/widening, are clinically significant indicators of toxicity. In small children, the ingestion of even a low dose is classified as potentially fatal.

When to Seek Immediate Help Regulatory instructions mandate that medical help must be sought right away for any suspected overdose. Emergency services must be contacted immediately if the individual has collapsed, experienced a seizure, or cannot be awakened.

Management is defined as symptomatic and supportive, requiring admission to a hospital or intensive care unit and continuous ECG monitoring for a minimum of 12 hours. A specific intervention, Sodium Bicarbonate, is indicated to reverse severe cardiac effects like QRS widening. The label advises treating convulsions with Benzodiazepines and using Activated Charcoal under controlled conditions.

Therapeutic Uses of Триптизол

What Триптизол Treats: Main Uses and Benefits

Триптизол is generally used to help manage four key symptomatic domains, supporting patients during difficult episodes by contributing to easing the overall symptom load. This medicine may be part of symptomatic management for Major Depressive Disorder (MDD), chronic neuropathic pain syndromes, the prophylaxis of recurrent headaches (migraine and tension-type), and specific conditions like nocturnal enuresis in children.

The medication is commonly applied across therapeutic domains where additional symptomatic support is needed, assisting with pronounced symptoms that interfere with daily functioning. The medicine's action provides supportive relief when symptoms cluster into patterns requiring complex management. This application provides supportive relief that may help patients cope more steadily with difficult episodes and contributes to improved comfort during symptomatic periods.


Quick Fact: Supportive Management for Chronic Pain
This therapeutic approach is commonly used when symptoms of long-lasting nerve pain require additional symptomatic management.

Eligibility and Restrictions for Use

The eligibility for using Триптизол (Amitriptyline) is strictly defined by regulatory authorities based on population group and concurrent health status.

Contraindicated Populations (Must Not Use)

Use of the medicine is contraindicated in patients with a history of recent Myocardial Infarction (MI) or pre-existing cardiac conduction disorders such as Heart Block. It is also prohibited for patients currently taking a Monoamine Oxidase Inhibitor (MAOI), or within 14 days of discontinuing an MAOI. Patients with severe liver disease or known hypersensitivity to amitriptyline are also excluded [1.1, 1.4].

Age and Condition Restrictions

Category Regulatory Status Context
Pediatric (Under 18) Not Recommended For depression, neuropathic pain, and headache prophylaxis [1.4].
Children (Under 6) Contraindicated For all uses [1.4].
Older Adults (Geriatric) Use with Caution Lower starting doses are required due to increased susceptibility to effects like hypotension [2.2].
Pregnancy/Lactation Not Recommended Should only be used if the potential benefit justifies the risk [1.2, 3.6].

Eligibility also requires caution in patients with a history of seizures, angle-closure glaucoma, or conditions causing urinary retention [1.1, 1.3].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Триптизол (Amitriptyline) is known to interact with several classes of medications and substances, potentially altering its effects or increasing the risk of adverse reactions. Concomitant use with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the risk of severe, life-threatening events, including hyperpyretic crises and Serotonin Syndrome. A mandatory washout period of at least 14 days is required when switching from an MAOI to amitriptyline.

The drug may enhance the effects of CNS depressants, including alcohol, barbiturates, and sedative medications, leading to increased drowsiness. Caution is also advised with co-administration of sympathomimetic agents, as amitriptyline can alter their effects by affecting neurotransmitter reuptake.

Amitriptyline is metabolized by certain liver enzymes, particularly CYP2D6 and CYP3A4. Co-administration with inhibitors of these enzymes, such as certain other antidepressants or cimetidine, can significantly increase amitriptyline plasma concentrations, raising the risk of toxicity.

Due to its cardiac effects, co-administration with other QT-prolonging drugs increases the risk of serious heart rhythm abnormalities. Furthermore, the combination with anticholinergic or neuroleptic medications may increase the risk of hyperpyrexia, especially in warm environments. Dose adjustments for antidiabetic therapy may be necessary, as amitriptyline can modify insulin and glucose responses.

Mechanism of Action

Dual Modulation of Norepinephrine and Serotonin Signaling

Триптизол's primary action involves simultaneously blocking the reuptake of both norepinephrine (NE) and serotonin (5-HT) by inhibiting their respective transporters (NET and SERT). This mechanism increases the concentration of NE and 5-HT in the synaptic cleft, triggering a sequence of adaptive changes (functional receptor density modulation) in the brain's signaling pathways over several weeks. This modulation of neural communication is linked to changes in the activity within central physiological systems.


Antagonism of Multiple Receptors and Systems

The molecule also acts as an antagonist (blocker) at several non-primary targets, notably the Histamine H1 and Muscarinic Acetylcholine receptors. This widespread antagonism suppresses histaminergic signaling, which influences central arousal signal generation, and disrupts cholinergic signaling, which affects autonomic functions including glandular secretion and smooth muscle activity.


Direct Stabilization of Nerve Excitability

A distinct mechanism involves the direct blockade of voltage-gated sodium channels (Nav) in nerve cell membranes. This mechanism reduces the excitability of nerve fibers, raising the threshold required for signal transmission. This action, alongside the enhanced descending inhibitory pathways resulting from the dual monoamine action, contributes to the modulation of peripheral nerve impulse transmission.

Dosage and Administration Information

How to Use Amitriptyline (Tryptizol)

Amitriptyline is an oral medication that should be taken exactly as prescribed by your healthcare provider. The tablets must be swallowed whole with water and should not be crushed or chewed, as they may have a bitter taste. Amitriptyline can be taken with or without food.

Administration and Dosage

Due to the sedative effects of this medication, it is typically recommended to take the entire daily dose as a single dose at bedtime to minimize daytime drowsiness. If you experience morning sedation, your doctor may suggest taking the dose earlier in the evening.

Treatment is generally started at a low dose and gradually increased over time to reach the optimal therapeutic effect. It may take several weeks to a month to feel the full benefit of the medication. Do not adjust your dose or stop taking the medicine suddenly without consulting your doctor, as abrupt discontinuation can lead to withdrawal symptoms such as headache, nausea, and general discomfort.


Missed Dose

  • If you miss a dose and remember it soon, take it as soon as possible. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.
  • Never take a double dose to make up for the one you missed.

Storage

Store the medication at room temperature, away from heat and moisture, and out of the reach of children and pets.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Primary Research Focus

Clinical research has historically focused on amitriptyline for its approved use in treating major depressive disorder. However, recent evidence is primarily concentrated on its application in managing various chronic, non-malignant pain conditions.

Key Findings from Clinical Trials

Phase III Randomized Controlled Trials (RCTs) have frequently investigated the treatment in patient cohorts experiencing chronic pain, often when symptoms have been refractory to conventional therapies. A key finding in many trials is that the treatment was associated with a change in pain intensity over trial periods, with studies commonly comparing outcomes against a placebo group.

  • Neuropathic Pain: Evidence has explored the treatment’s potential in managing pain associated with nerve damage, such as post-herpetic neuralgia and painful diabetic neuropathy. While long used in this capacity, evidence quality for some specific neuropathic conditions is noted as being mixed.
  • Irritable Bowel Syndrome (IBS): Recent large-scale RCTs have demonstrated that low-dose administration was associated with a significant improvement in global IBS symptoms and abdominal pain severity scores compared to placebo at six months. The effect was observed independently of changes in anxiety or depression scores.

Safety Profile and Limitations

Research has consistently reported that common adverse events include symptoms related to the drug's known properties, such as dry mouth, drowsiness, and dizziness. These events were often observed to be mild or moderate in severity and transient. Studies investigating the long-term changes in pain status have frequently reported limited long-term data regarding the persistence of benefit and the full safety profile.

Key Studies & References

  1. Neuropathic pain in adults: pharmacological management in non-specialist settings (NICE Guideline CG173 - relevant section on initial treatment choice)
  2. Adverse Effects of Antidepressants for Chronic Pain: A Systematic Review and Meta-analysis (Frontiers in Neurology - for safety and tolerability)

Frequently Asked Questions (FAQ)

Common questions about Триптизол (FAQ)

Q: What is the main difference between Триптизол and other common antidepressants?

A: Amitriptyline is classified as a tricyclic antidepressant (TCA). Official product information states its primary mechanism involves inhibiting the reuptake of both norepinephrine and serotonin. It is also noted for having marked anticholinergic and sedative effects, making its profile distinct from many newer antidepressants.

Q: Can Триптизол cause changes in body weight?

A: Regulatory documents list weight gain as a common side effect, potentially affecting up to 1 in 10 people who use the medication. However, weight change is considered an individual response and is a topic for discussion with a healthcare provider.

Q: What are the most frequent reasons doctors prescribe Триптизол?

A: The approved uses listed in official labeling include the treatment of major depressive disorder, certain types of neuropathic pain, and the prevention of chronic tension-type headaches and migraines.

Q: Can you safely take Триптизол if you already take pain relief medicine?

A: Caution is generally advised with other medications that affect the central nervous system (CNS), including many types of pain relief medicines. Amitriptyline may enhance the effects of CNS depressants, increasing risks like drowsiness. It is important that the prescriber is informed of all medicines being taken.

Q: Are there certain foods or drinks that should be completely avoided while using Триптизол?

A: Official warnings describe alcohol consumption as being generally discouraged while using this medicine. This is because the combination can enhance the sedative effects of both substances, leading to increased drowsiness or risk of adverse effects.

Q: Is it normal to have vivid dreams or nightmares on Триптизол?

A: Disturbances in attention and confusion are listed as common side effects. More specifically, vivid dreams are categorized in official documents as uncommon side effects, meaning they affect up to 1 in 100 people.

Q: Does the evidence show that Триптизол is effective for long-term use?

A: For conditions like depression, official guidelines suggest continuing treatment for at least six months after recovery to help prevent a relapse. For pain treatment, it is intended to be used for an appropriate period necessary to manage symptoms effectively.

Q: Is it okay to take over-the-counter cold medicine while on Триптизол?

A: Caution is required with many over-the-counter cold medicines, especially those containing sympathomimetic agents (which affect neurotransmitters) or ingredients that cause drowsiness. The combination can increase the risk of certain side effects.

Q: What are the signs that Триптизол might be starting to work?

A: Official information indicates that the full therapeutic effect for both antidepressant and pain-relieving uses typically begins after two to four weeks of consistent dosing. The onset of effects is gradual.

Q: Are there any common reasons why a doctor might decide to stop a patient's Триптизол treatment?

A: A doctor may decide to discontinue the medicine if a patient enters a manic phase (in those with bipolar disorder) or experiences serious cardiac toxicity. Any severe adverse reaction is a common reason for a clinical decision to stop therapy.

Q: What kind of monitoring might a doctor recommend while taking Триптизол?

A: Official documentation describes that close monitoring is required for clinical worsening, particularly the emergence of suicidal thoughts or behavior, as per the FDA Boxed Warning. An ECG (heart tracing) may also be recommended prior to or during treatment, particularly for elderly patients.

Q: Are there different forms of Триптизол available, like liquid or tablets?

A: The medicine is commonly available as film-coated oral tablets in various strengths. Official regulatory reports also recognize a solution for injection, which may be used in hospital settings in some regions.

Q: Are there any safety warnings about Триптизол and driving or operating machinery?

A: Official product information contains a specific warning that the medicine can cause drowsiness and dizziness. The labeling states that there is a risk of impaired ability to drive or operate heavy machinery.

Q: Can I use herbal supplements while taking Триптизол?

A: Caution is recommended with herbal products, especially those that can increase the risk of sedation or interact with the liver enzymes that break down the medication. St. John's Wort is sometimes specifically noted as a concern for increasing the risk of adverse effects.

Q: What is the typical time frame before a doctor might adjust the use of Триптизол?

A: Official guidelines state that for treating pain, the dose may be gradually increased every three to seven days. For depression, a dose adjustment may be made by the clinician after a one-week review, if deemed necessary.

Q: Is Триптизол generally classified as habit-forming?

A: Regulatory information indicates the medicine is generally not classified as a controlled substance in the United States. However, it is explicitly warned that stopping the medicine suddenly can lead to uncomfortable withdrawal symptoms.

Q: What should be done if a potential side effect is noticed?

A: Regulatory documents state that patients, family members, and caregivers must contact the prescriber right away to report any new or sudden changes in mood, behavior, thoughts, or feelings. Follow-up visits should be kept as scheduled.

Q: Is it possible for Триптизол to make anxiety worse initially?

A: Anxiety and agitation are listed as potential side effects in official drug labels, categorized as common or uncommon depending on the specific term. This indicates that worsening anxiety is a known possible reaction.

Q: Are there specific symptoms that mean Триптизол is not working well for someone?

A: Official warnings emphasize that clinical worsening or the emergence of new suicidal thoughts or behaviors after starting therapy are critical signs. Regulatory guidelines indicate these symptoms require immediate professional monitoring and are critical signs for discussion with a healthcare provider.

Q: Are there any known interactions between Триптизол and birth control pills?

A: Amitriptyline is metabolized (broken down) by specific liver enzymes, including CYP3A4 and CYP2D6. Because some oral contraceptives may influence the activity of these enzymes, making a discussion regarding potential interactions with a healthcare provider relevant.

Q: Can Триптизол affect blood pressure readings?

A: Orthostatic hypotension (a drop in blood pressure upon standing that can cause dizziness) is listed as a very common side effect. Hypertension (high blood pressure) is also listed as an uncommon side effect.

Q: Does the use of Триптизол have any effect on appetite?

A: Official documents list both increased appetite and decreased appetite as potential side effects of the medicine, categorized as either common or uncommon.

Q: What is meant by the term 'tricyclic' antidepressant?

A: The drug is classified pharmacologically as a tricyclic antidepressant (TCA). This term refers to its distinct chemical structure, which contains three fused rings, as described in the official product description.

Q: Is there a link between Триптизол and increased sun sensitivity?

A: Increased sensitivity to the sun, known as a photosensitivity reaction, is listed in regulatory documents as a rare side effect, meaning it may affect less than 1 in 1,000 people.

Q: What are the common benefits people report from taking Триптизол?

A: The expected therapeutic goals, according to the indications, are the successful relief of symptoms of depression, the management of neuropathic pain, and the reduction in the frequency of headaches and migraines.

Q: Are there any specific liver or kidney concerns with Триптизол use?

A: Official information lists severe liver disease as a contraindication, meaning the medicine should not be used in this circumstance. Regulatory guidelines state that for patients with reduced renal (kidney) function, the medication can generally be given at usual doses.

Q: What does research say about Триптизол for conditions other than depression and pain?

A: In addition to pain and depression, the drug is officially indicated for the treatment of nocturnal enuresis (bedwetting) in children aged six and above. This use is generally reserved after other treatments have failed and any physical causes have been ruled out.

Q: Is Триптизол considered a controlled substance in many places?

A: In the United States, Amitriptyline is currently not scheduled as a controlled substance by the Drug Enforcement Administration (DEA).

Q: What happens to Триптизол in the body after it is taken?

A: Official pharmacokinetic data indicates the medicine is readily absorbed after it is taken and is metabolized in the liver into its active compound, nortriptyline. The drug and its byproducts are then primarily eliminated through the urine and feces.

Q: Does the official information mention any long-term side effects?

A: Official labeling includes warnings about serious risks that require monitoring across the duration of therapy. These include the Black Box Warning for suicidal thoughts in young adults and the risk of cardiac arrhythmias (abnormal heart rhythms).

How should Триптизол be stored and disposed of?

How to Store and Dispose of Triptizol (Amitriptyline)

Official regulations define specific conditions for storing and discarding amitriptyline hydrochloride to maintain its stability and ensure safety.

Storage Requirements

Detail Official Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep from freezing and protect from heat, moisture, and direct light.
Container Store in a tightly sealed, light-resistant container.
Safety Must be kept out of the sight and reach of children and pets, preferably locked up.

Disposal

Unused or expired medicine should be disposed of via a community drug take-back program or an authorized collector. If this option is not available, the product should be mixed with an undesirable substance (e.g., dirt, coffee grounds), placed in a sealed container, and then discarded in the household trash. The medicine must not be allowed to enter sewers or water systems, as it is classified as toxic to aquatic life.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Триптизол found in:

A-Z Index: